Project Details
Description
RANDOMIZED, DOUBLE-MASKED, MULTI-CENTER, 3-ARM PIVOTAL PHASE 2/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVITREAL EYE103 COMPARED WITH INTRAVITREAL RANIBIZUMAB (0.5MG) IN PARTICIPANTS WITH DIABETIC MACULAR EDEMA
| Status | Active |
|---|---|
| Effective start/end date | 12/19/24 → 12/18/26 |
Funding
- EYEBIOTECH LIMITED
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.